Complete remission after the first cycle of induction chemotherapy determines the clinical efficacy of relapse-preventive immunotherapy in acute myeloid leukaemia
Introductory text in journal, 2020

No abstract available

aml

immunotherapy

IL-2

histamine dihydrochloride

chemotherapy

Author

Malin S. Nilsson

University of Gothenburg

Alexander Hallner

University of Gothenburg

Mats Brune

University of Gothenburg

Staffan Nilsson

Chalmers, Mathematical Sciences, Applied Mathematics and Statistics

University of Gothenburg

Fredrik B. Thoren

University of Gothenburg

Anna Martner

University of Gothenburg

Kristoffer Hellstrand

University of Gothenburg

British Journal of Haematology

0007-1048 (ISSN) 1365-2141 (eISSN)

Vol. 188 4 e49-e53

Subject Categories

Pediatrics

Hematology

Cancer and Oncology

DOI

10.1111/bjh.16320

More information

Latest update

9/28/2020